1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
  4. > Wound Closure and Advanced Wound Care Global Market – Forecast To 2021

Wound Closure and Advanced Wound Care Global Market – Forecast To 2021

  • December 2015
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 413 pages

Wound closure and wound care devices are the medical apparatus used for the closure of the wound by pulling the cut edges of the tissues together or by directly acting on the wounds for better healing. Devices such as sutures, strips, sealants and adhesives, clips, staples, energy based devices, haemostats and skin grafts are used to minimize the trauma and infection leading to a better and a scar-free healing. The wound closure and advanced wound care global market is segmented based on the products, applications, end-users and geography. Products are divided into primary and secondary wound closure products. Primary wound closure devices include surgical sutures, wound closure strips, staples, ligating clips, haemostat, adhesives and sealants. Surgical suture market is segmented into suture and automated suturing device. Suture market is further divided based on types, filaments, and material type. Sealants are divided into natural and synthetic sealant. Natural sealants are collagen, fibrin and albumin. Synthetic sealants are divided into cyanoacrylate, polymer and others. Haemostats are divided into flowable haemostats, fibrin sealants, mechanical haemostats and active haemostats.

Secondary wound closure devices include energy based devices, therapy based devices, moist wound therapy and biologics. Energy based devices are divided into laser devices, electrical stimulations, electromagnetic stimulations, ultra sound therapy, radio frequency therapy and ultra violet therapy. Therapy based devices are further segmented into hyperbaric oxygen therapy, negative pressure wound therapy and pressure relief devices. Biologics are divided into skin grafts and growth factor. Moist wound therapy is segmented into film, foam, hydrocolloids, hydrogels, alginate and collagen dressings.

By application, the wound closure and advanced wound care markets are divided into burns, ulcers, surgical wounds, trauma and laceration and radionecrosis. Ulcers are further divided into pressure ulcers, arterial ulcers, venous leg ulcers and diabetic foot ulcers. Surgical wound are divided into general surgery, cardio vascular surgery, neuro and spine surgery, ENT surgery, orthopaedic surgery, urology surgery, oncology surgery, obstetrics and gynaecology surgery and plastics, cosmetics and reconstruction surgery. Based on the end- users they are segmented into hospitals, community healthcare services and home healthcare.

Among the wound closure and advanced wound care products, the primary wound closure market dominated the products market by occupying a largest share. At the same time, secondary wound closure market is the fastest growing segment from 2014 to 2021. In applications, the surgical wounds are the largest segment with XX% share and ulcers are the fastest growing segment with single high digit CAGR from 2014 to 2021.

By end- users, hospitals is the largest segment with a share of XX% and also, the fastest segment with a CAGR of 7.4% from 2014 to 2021.Geographical wise, North America is the largest market, followed by Europe and Asia. The APAC region is the fastest growing region with single high digit CAGR from 2014 to 2021 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the wound closure and advanced wound care market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.

The wound closure and advanced wound care market is expected to grow steadily CAGR during 2014 to 2021. The factors driving the growth of this market are rising prevalence of lifestyle diseases such as diabetes and cardiovascular and related surgeries drive the demand for sophisticated tissue sealing alternatives, new technology products boosting wound closure and advanced wound care products market growth, increase in aging population, increase in volume of surgeries, government initiatives and wide range of available products likely to propel the wound care market. In addition to this, increasing prevalence of chronic wounds, optimised therapy based devices, healthy growth in the biological products and acquisitions to open an array of opportunities for the market to flourish are some of the opportunities that are propelling the growth of the market. However, lack of trained physicians restraining market growth of advanced wound closure and care products, high cost of sealants and glues impeding effective penetration in low- and middle-income countries, unfavourable reimbursement policies and reluctance in adoption of new technologies are hampering the growth of the market. The threats for the wound closure and advanced wound care market include survival of small players & new entrants and decreasing R&D funding will impact on innovation.

The wound closure and advanced wound care global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the wound closure and advanced wound care market are Smith & Nephew (U.K.), Johnson and Johnson (U.S), Medtronic (Ireland), 3M healthcare (U.S), Kinetic Concepts (U.S.), Coloplast (Denmark), Abbott laboratories (U.S.), C.R.Bard (U.S.), Baxter International (U.S.),Cardinal Health (U.S.), Integra life science (U.S.) and B. Braun Melsungen AG (Germany).

The report provides an in depth market analysis of the above mentioned segments across the following regions:
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)

Table Of Contents

Wound Closure and Advanced Wound Care Global Market - Forecast To 2021
1 EXECUTIVE SUMMARY 30
2 INTRODUCTION 36
2.1 KEY TAKE AWAYS 36
2.2 REPORT DESCRIPTION 36
2.3 MARKETS COVERED 39
2.4 STAKEHOLDERS 41
2.5 RESEARCH METHODOLOGY 41
2.5.1 MARKET SIZE ESTIMATION 43
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 46
2.5.3 SECONDARY SOURCES 47
2.5.4 PRIMARY SOURCES 48
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 48
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 49
2.5.7 ASSUMPTIONS 50
3 MARKET ANALYSIS 51
3.1 INTRODUCTION 51
3.2 MARKET SEGMENTATION 52
3.3 FACTORS INFLUENCING MARKET 55
3.3.1 DRIVERS AND OPPORTUNITIES 56
3.3.1.1 Rising prevalence of lifestyle diseases such as diabetes and cardiovascular and related surgeries drive the demand for sophisticated tissue sealing alternatives 56
3.3.1.2 Increase in aging population 56
3.3.1.3 Increase in volume of Surgeries 57
3.3.1.4 New technology products boosting wound closure and advanced wound care market growth 58
3.3.1.5 Government initiatives likely to propel the wound care market 58
3.3.1.6 Wide range of available products 59
3.3.1.7 Healthy growth in biological products 59
3.3.1.8 Optimized therapy based devices 60
3.3.1.9 Increasing prevalence of chronic wounds 60
3.3.1.10 Acquisitions to open an array of opportunities for the
market to flourish 61
3.3.2 RESTRAINTS AND THREATS 62
3.3.2.1 Lack of trained physicians 62
3.3.2.2 High cost of sealants and glues impeding effective penetration
in low and middle income countries 63
3.3.2.3 Unfavorable reimbursement policies 63
3.3.2.4 Reluctance in adoption of new technologies 64
3.3.2.5 Survival of small players and new entrants 64
3.3.2.6 Dependence on RandD Funding will Impact on Innovation 65
3.4 REGULATORY AFFAIRS 65
3.4.1 U.S. 65
3.4.2 EUROPE 66
3.4.3 INDIA 67
3.4.4 CHINA 67
3.4.5 JAPAN 68
3.5 REIMBURSEMENT 69
3.5.1 ABDOMINALPLASTY 69
3.5.2 STERNUM REPAIR 69
3.5.3 MAMOPLASTY 70
3.5.4 MASTECTOMY 70
3.5.5 CARDIAC- BYPASS 72
3.5.6 CARDIAC-VALVE REPLACEMENT OR REPAIR 72
3.5.7 CARDIAC-VESSEL REPAIR 74
3.5.8 ORTHOPAEDIC HIP-KNEE REPLACEMENT 75
3.5.9 ULTRASOUND THERAPY FOR WOUNDS 76
3.5.10 HYPERBARIC OXYGEN THERAPY 77
3.5.11 NEGATIVE PRESSURE WOUND THERAPY 77
3.5.12 GROWTH FACTORS 78
3.5.13 ELECTRIC STIMULATION THERAPY 78
3.5.14 ELECTROMAGNETIC THERAPY 79
3.6 UPCOMING TECHNOLOGIES 79
3.7 BIOMATERIALS 84
3.8 PATENT TRENDS 91
3.9 PORTER'S FIVE FORCE ANALYSIS 93
3.9.1 THREAT OF NEW ENTRANTS 93
3.9.2 THREAT OF SUBSTITUTES 94
3.9.3 BARGAINING POWER OF SUPPLIERS 94
3.9.4 BARGAINING POWER OF BUYERS 95
3.9.5 COMPETITIVE RIVALRY 96
3.10 SUPPLY CHAIN ANALYSIS 96
3.11 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 98
4 WOUND CLOSURE AND ADVANCED WOUND CARE MARKET, BY PRODUCT 101
4.1 INTRODUCTION 101
4.2 PRIMARY WOUND CLOSURE 105
4.2.1 SURGICAL SUTURES 108
4.2.1.1 Sutures 110
4.2.1.1.1 Suture, by Type 112
4.2.1.1.1.1 Absorbable suture 113
4.2.1.1.1.2 Non-Absorbable Suture 115
4.2.1.1.2 Suture, by Material Type 117
4.2.1.1.2.1 Natural 117
4.2.1.1.2.2 Synthetic 118
4.2.1.1.3 Suture by Filament Type 118
4.2.1.1.3.1 Monofilament 119
4.2.1.1.3.2 Multifilament 119
4.2.1.2 Automated Suturing Devices 120
4.2.2 WOUND CLOSURE STRIPS 122
4.2.3 STAPLES 124
4.2.4 LIGATING CLIPS 125
4.2.5 ADHESIVES AND SEALANTS 127
4.2.5.1 Adhesives 129
4.2.5.2 Sealants 130
4.2.5.2.1 Natural sealants 134
4.2.5.2.1.1 Collagen Based Sealants 136
4.2.5.2.1.2 Fibrin Sealants 137
4.2.5.2.1.3 Albumin Based Sealants 139
4.2.5.2.2 Synthetic Sealants 140
4.2.5.2.2.1 Cyanoacrylate Sealants 143
4.2.5.2.2.2 Polymer Based Sealants 144
4.2.5.2.2.3 Other Sealants 145
4.2.6 HAEMOSTATS 147
4.2.6.1 Flowable haemostats 150
4.2.6.2 Fibrin haemostats 151
4.2.6.3 Mechanical haemostats 153
4.2.6.4 Active Haemostats 154
4.3 SECONDARY WOUND CLOSURES 156
4.3.1 BIOLOGICS 160
4.3.1.1 Skin grafts 162
4.3.1.2 Growth factors 164
4.3.2 THERAPY BASED DEVICES 165
4.3.2.1 Hyperbaric oxygen therapy device 169
4.3.2.2 Negative pressure wound therapy 170
4.3.2.3 Pressure relief devices 172
4.3.3 ENERGY BASED DEVICES 173
4.3.3.1 Ultrasound therapy devices 175
4.3.3.2 Laser therapy devices 175
4.3.3.3 Electrical stimulation devices 176
4.3.3.4 Electromagnetic devices 176
4.3.3.5 Radiofrequency therapy 177
4.3.3.6 Ultra violet devices 177
4.3.4 MOIST WOUND THERAPY 178
4.3.4.1 Film dressings 179
4.3.4.2 Foam dressings 180
4.3.4.3 Hydrocolloid dressing 181
4.3.4.4 Hydrogel dressings 181
4.3.4.5 Alginate dressings 182
4.3.4.6 Collagen dressings 182
5 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET, BY APPLICATIONS 184
5.1 INTRODUCTION 184
5.2 BURNS 186
5.3 ULCERS 188
5.3.1 PRESSURE ULCERS 191
5.3.2 VENOUS LEG ULCERS 193
5.3.3 DIABETIC FOOT ULCERS 194
5.3.4 ARTERIAL ULCERS 196
5.4 SURGICAL WOUNDS 197
5.4.1 GENERAL SURGERY 202
5.4.2 UROLOGY SURGERY 203
5.4.3 ORTHOPAEDIC SURGERY 205
5.4.4 OBSTETRICS AND GYNAECOLOGY SURGERY 206
5.4.5 PLASTICS, COSMETIC AND RECONSTRUCTION SURGERY 208
5.4.6 ONCOLOGY 210
5.4.7 CARDIOVASCULAR SURGERY 212
5.4.8 NEURO AND SPINE SURGERY 213
5.4.9 ENT SURGERY 215
5.5 TRAUMA LACERATIONS 217
5.6 RADIONECROSIS 218
6 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET, BY END-USERS 221
6.1 INTRODUCTION 221
6.2 HOSPITALS 223
6.3 COMMUNITY HEALTH SERVICES 225
6.4 HOME HEALTH CARE 227
7 WOUND CLOSURE AND ADVANCED WOUND CARE MARKET,
BY GEOGRAPHY 229
7.1 INTRODUCTION 229
7.2 NORTH AMERICA 231
7.3 EUROPE 248
7.4 ASIA PACIFIC 265
7.4.1 INDIA 265
7.5 REST OF THE WORLD 283
8 COMPANY DEVELOPMENTS 300
8.1 INTRODUCTION 300
8.1.1 MERGERS AND ACQUISITIONS AS A MAJOR GROWTH STRATEGY OF WOUND CLOSURE and ADVANCED WOUND CARE MARKETPLAYERS 301
8.2 MERGERS AND ACQUISITIONS 301
8.3 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS and JOINT VENTURES 308
8.4 NEW PRODUCT LAUNCH 313
8.5 APPROVAL 317
8.6 BUSINESS EXPANSION 319
8.7 OTHER DEVELOPMENTS 321
9 COMPANY PROFILE 322
9.1 3M 322
9.1.1 OVERVIEW 322
9.1.2 FINANCIALS 323
9.1.3 PRODUCT PORTFOLIO 325
9.1.4 KEY DEVELOPMENTS 326
9.1.5 BUSINESS STRATEGY 327
9.1.6 SWOT ANALYSIS 328
9.2 ABBOTT LABORATORIES 329
9.2.1 OVERVIEW 329
9.2.2 FINANCIALS 330
9.2.3 PRODUCT PORTFOLIO 333
9.2.4 KEY DEVELOPMENTS 334
9.2.5 BUSINESS STRATEGY 335
9.2.6 SWOT ANALYSIS 336
9.3 ACELITY LTD (KCI and SYSTAGENIX) 337
9.3.1 OVERVIEW 337
9.3.2 FINANCIALS 338
9.3.3 PRODUCT PORTFOLIO 340
9.3.4 KEY DEVELOPMENTS 341
9.3.5 BUSINESS STRATEGY 342
9.3.6 SWOT ANALYSIS 343
9.4 BAXTER INTERNATIONAL, INC 344
9.4.1 OVERVIEW 344
9.4.2 FINANCIALS 344
9.4.3 PRODUCT PORTFOLIO 348
9.4.4 KEY DEVELOPMENTS 349
9.4.5 BUSINESS STRATEGY 351
9.4.6 SWOT ANALYSIS 352
9.5 B. BRAUN MELSUNGEN AG 353
9.5.1 OVERVIEW 353
9.5.2 FINANCIALS 354
9.5.3 PRODUCT PORTFOLIO 357
9.5.4 KEY DEVELOPMENTS 358
9.5.5 BUSINESS STRATEGY 360
9.5.6 SWOT ANALYSIS 361
9.6 CARDINAL HEALTH INC. 362
9.6.1 OVERVIEW 362
9.6.2 FINANCIALS 363
9.6.3 PRODUCT PORTFOLIO 366
9.6.4 KEY DEVELOPMENTS 367
9.6.5 BUSINESS STRATEGY 369
9.6.6 SWOT ANALYSIS 370
9.7 C.R.BARD INC. 371
9.7.1 OVERVIEW 371
9.7.2 FINANCIALS 372
9.7.3 PRODUCT PORTFOLIO 374
9.7.4 KEY DEVELOPMENTS 375
9.7.5 BUSINESS STRATEGY 375
9.7.6 SWOT ANALYSIS 376
9.8 COLOPLAST 377
9.8.1 Overview 377
9.8.2 FINANCIALS 378
9.8.3 PRODUCT portfolio 379
9.8.4 key DEVELOPMENTS 380
9.8.5 business Strategy 381
9.8.6 SWoT ANALYSIS 382
9.9 INTEGRA LIFESCIENCES CORPORATION 383
9.9.1 OVERVIEw 383
9.9.2 FINANCIALS 383
9.9.3 PRODUCT PORTFOLIO 385
9.9.4 KEY DEVELOPMENTS 387
9.9.5 BUSINESS STRATEGY 388
9.9.6 SWOT ANALYSIS 389
9.10 JOHNSON and JOHNSON (ETHICON) 390
9.10.1 OVERVIEW 390
9.10.2 FINANCIALS 391
9.10.3 PRODUCT PORTFOLIO 392
9.10.4 KEY DEVELOPMENTS 394
9.10.5 BUSINESS STRATEGY 395
9.10.6 SWOT ANALYSIS 396
9.11 MEDTRONIC INC 397
9.11.1 OVERVIEW 397
9.11.2 FINANCIALS 398
9.11.3 PRODUCT PORTFOLIO 400
9.11.4 KEY DEVELOPMENTS 403
9.11.5 BUSINESS STRATEGY 404
9.11.6 SWOT ANALYSIS 405
9.12 SMITH and NEPHEW PLC 406
9.12.1 OVERVIEW 406
9.12.2 FINANCIALS 407
9.12.3 PRODUCT PORTFOLIO 409
9.12.4 KEY DEVELOPMENTS 410
9.12.5 BUSINESS STRATEGY 411
9.12.6 SWOT ANALYSIS 412




















LIST OF TABLES

TABLE 1 GLOBAL WOUND CLOSURE and ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN) 33
TABLE 2 GLOBAL WOUND CLOSURE and ADVANCED WOUND CARE MARKET,
BY PRODUCT, (2013-2021) ($MN) 33
TABLE 3 GLOBAL WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 34
TABLE 4 GLOBAL WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE, BY END-USER, (2013-2021) ($MN) 35
TABLE 5 GLOBAL WOUND CLOSURE and ADVANCED WOUND CARE MARKET,
BY PRODUCT, (2013-2021) ($MN) 104
TABLE 6 GLOBAL PRIMARY WOUND CLOSURE MARKET, BY REGION,
(2013-2021) ($MN) 107
TABLE 7 GLOBAL PRIMARY WOUND CLOSURE MARKET, BY TYPE,
(2013-2021) ($MN) 108
TABLE 8 GLOBAL SURGICAL SUTURES MARKET, BY REGION, (2013-2021) ($MN) 109
TABLE 9 GLOBAL SURGICAL SUTURES MARKET, BY TYPE, (2013-2021) ($MN) 110
TABLE 10 GLOBAL SUTURES MARKET, BY REGION, (2013-2021) ($MN) 112
TABLE 11 GLOBAL SUTURES MARKET, BY TYPE, (2013-2021) ($MN) 113
TABLE 12 GLOBAL ABSORABLE SUTURES MARKET, BY REGION, (2013-2021) ($MN) 115
TABLE 13 GLOBAL NON-ABSORABLE SUTURES MARKET, BY REGION,
(2013-2021) ($MN) 116
TABLE 14 GLOBAL AUTOMATED SUTURING DEVICES MARKET, BY REGION,
(2013-2021) ($MN) 122
TABLE 15 GLOBAL WOUND CLOSURE STRIPS MARKET, BY REGION,
(2013-2021) ($MN) 123
TABLE 16 GLOBAL STAPLES MARKET, BY REGION, (2013-2021) ($MN) 125
TABLE 17 GLOBAL LIGATING CLIPS MARKET, BY REGION, (2013-2021) ($MN) 126
TABLE 18 GLOBAL ADHESIVE and SEALANTS MARKET, BY REGION, (2013-2021) ($MN) 128
TABLE 19 GLOBAL ADHESIVE and SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 128
TABLE 20 GLOBAL ADHESIVES MARKET, BY REGION, (2013-2021) ($MN) 130
TABLE 21 GLOBAL SEALANTS MARKET, BY REGION, (2013-2021) ($MN)) 133
TABLE 22 GLOBAL SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 133
TABLE 23 GLOBAL NATURAL SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 135
TABLE 24 GLOBAL NATURAL SEALANTS MARKET, BY REGION, (2013-2021) ($MN) 135
TABLE 25 GLOBAL COLLAGEN SEALANTS MARKET, BY REGION, (2013-2021) ($MN) 137
TABLE 26 GLOBAL FIBRIN SEALANTS MARKET, BY REGION, (2013-2021) ($MN) 138
TABLE 27 GLOBAL ALBUMIN SEALANTS MARKET, BY REGION, (2013-2021) ($MN) 140
TABLE 28 GLOBAL SYNTHETIC SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 142
TABLE 29 GLOBAL SYNTHETIC SEALANTS MARKET, BY REGION, (2013-2021) ($MN) 142
TABLE 30 GLOBAL CYANOACRYLATE SEALANTS MARKET, BY REGION,
(2013-2021) ($MN) 144
TABLE 31 GLOBAL POLYMER BASED SEALANTS MARKET, BY REGION,
(2013-2021) ($MN) 145
TABLE 32 GLOBAL OTHERS SEALANTS MARKET, BY REGION, (2013-2021) ($MN) 146
TABLE 33 GLOBAL HAEMOSTATS MARKET, BY REGION, (2013-2021) ($MN) 149
TABLE 34 GLOBAL HAEMOSTATS MARKET, BY TYPE, (2013-2021) ($MN) 149
TABLE 35 GLOBAL FLOWABLE HAEMOSTATS MARKET, BY REGION,
(2013-2021) ($MN) 151
TABLE 36 GLOBAL FIBRIN HAEMOSTATS MARKET, BY REGION, (2013-2021) ($MN) 153
TABLE 37 GLOBAL MECHANICAL HAEMOSTATS MARKET, BY REGION,
(2013-2021) ($MN) 154
TABLE 38 GLOBAL ACTIVE HAEMOSTATS MARKET, BY REGION, (2013-2021) ($MN) 156
TABLE 39 GLOBAL SECONDARY WOUND CLOSURE MARKET, BY REGION,
(2013-2021) ($MN) 159
TABLE 40 GLOBAL SECONDARY WOUND CLOSURE MARKET, BY TYPE,
(2013-2021) ($MN) 159
TABLE 41 GLOBAL BIOLOGICS MARKET, BY TYPE, (2013-2021) ($MN) 161
TABLE 42 GLOBAL BIOLOGICS MARKET, BY REGION, (2013-2021) ($MN) 162
TABLE 43 GLOBAL SKIN GRAFTS MARKET, BY REGION, (2013-2021) ($MN) 163
TABLE 44 GLOBAL GROWTH FACTORS MARKET, BY REGION, (2013-2021) ($MN) 165
TABLE 45 GLOBAL THERAPY BASED DEVICES MARKET, BY REGION,
(2013-2021) ($MN) 168
TABLE 46 GLOBAL THERAPY BASED DEVICES MARKET, BY TYPE, (2013-2021) ($MN) 168
TABLE 47 GLOBAL HYPERBARIC OXYGEN THERAPY MARKET, BY REGION,
(2013-2021) ($MN) 170
TABLE 48 GLOBAL NEGATIVE PRESSURE WOUND THERAPY MARKET, BY REGION, (2013-2021) ($MN) 171
TABLE 49 GLOBAL PRESSURE RELIEF DEVICE MARKET, BY REGION,
(2013-2021) ($MN) 173
TABLE 50 GLOBAL ENERGY BASED DEVICES MARKET, BY REGION,
(2013-2021) ($MN) 174
TABLE 51 GLOBAL MOIST WOUND THERAPY MARKET, BY REGION,
(2013-2021) ($MN) 179
TABLE 52 GLOBAL WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 186
TABLE 53 GLOBAL BURNS WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 188
TABLE 54 GLOBAL ULCERS WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 190
TABLE 55 GLOBAL ULCERS WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY TYPE, (2013-2021) ($MN) 191
TABLE 56 GLOBAL PRESSURE ULCERS WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 192
TABLE 57 GLOBAL VENOUS LEG ULCERS WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 194
TABLE 58 GLOBAL DIABETIC FOOT ULCERS WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 195
TABLE 59 GLOBAL ARTERIAL ULCERS WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 197
TABLE 60 GLOBAL SURGICAL WOUNDS APPLICATION MARKET, BY REGION,
(2013-2021) ($MN) 200
TABLE 61 GLOBAL SURGICAL WOUNDS APPLICATION MARKET, BY TYPE,
(2013-2021) ($MN) 201
TABLE 62 GLOBAL GENERAL SURGERY WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 203
TABLE 63 GLOBAL UROLOGY SURGERY WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 204
TABLE 64 GLOBAL ORTHOPAEDIC SURGERY WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 206
TABLE 65 GLOBAL OBSTETRICS and GYNAECOLOGY SURGERY WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION,
(2013-2021) ($MN) 208
TABLE 66 GLOBAL PLASTICS, COSMETICS and RECONSTRUCTION SURGERY WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 210
TABLE 67 GLOBAL ONCOLOGY SURGERY WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 211
TABLE 68 GLOBAL CARDIOVASCULAR SURGERY WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 213
TABLE 69 GLOBAL NEURO and SPINE SURGERY WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 215
TABLE 70 GLOBAL ENT SURGERY WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 216
TABLE 71 GLOBAL TRAUMA LACERATIONS WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION, (2013-2021) ($MN) 218
TABLE 72 GLOBAL RADIONECROSIS WOUND CLOSURE and ADVANCED WOUND CARE APPLICATION MARKET, BY REGION (2013-2021) ($MN) 220
TABLE 73 GLOBAL WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE, BY END-USER, (2013-2021) ($MN) 223
TABLE 74 GLOBAL HOSPITALS WOUND CLOSURE and ADVANCED WOUND CARE END-USER MARKET REVENUE, BY REGION, (2013-2021) ($MN) 225
TABLE 75 GLOBAL COMMUNITY HEALTH SERVICES WOUND CLOSURE and ADVANCED WOUND CARE END-USER MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 226
TABLE 76 GLOBAL HOME HEALTH CARE WOUND CLOSURE and ADVANCED WOUND CARE END-USER MARKET REVENUE, BY REGION, (2013-2021) ($MN) 228
TABLE 77 NORTH AMERICAN WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCT, (2013-2021) ($MN) 233
TABLE 78 NORTH AMERICAN PRIMARY WOUND CLOSURE MARKET REVENUE,
BY TYPE, (2013-2021) ($MN) 234
TABLE 79 NORTH AMERICAN SURGICAL SUTURES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 235
TABLE 80 NORTH AMERICAN SUTURE MARKET, BY TYPE, (2013-2021) ($MN) 236
TABLE 81 NORTH AMERICAN ADHESIVE and SEALANTS MARKET, BY TYPE,
(2013-2021) ($MN) 237
TABLE 82 NORTH AMERICAN SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 237
TABLE 83 NORTH AMERICAN NATURAL SEALANTS MARKET, BY TYPE,
(2013-2021) ($MN) 238
TABLE 84 NORTH AMERICAN SYNTHETIC SEALANTS MARKET, BY TYPE,
(2013-2021) ($MN) 239
TABLE 85 NORTH AMERICAN HAEMOSTATS MARKET, BY TYPE, (2013-2021) ($MN) 240
TABLE 86 NORTH AMERICAN SECONDARY WOUND CLOSURE MARKETREVENUE,
BY TYPE, (2013-2021) ($MN) 241
TABLE 87 NORTH AMERICAN THERAPY BASED DEVICES MARKET, BY TYPE,
(2013-2021) ($MN) 242
TABLE 88 NORTH AMERICAN BIOLOGICS MARKET, BY TYPE, (2013-2021) ($MN) 243
TABLE 89 NORTH AMERICAN WOUND CLOSURE and ADVANCED WOUND CARE MARKETREVENUE, BY APPLICATION, (2013-2021) ($MN) 244
TABLE 90 NORTH AMERICAN ULCERS MARKET, BY TYPE, (2013-2021) ($MN) 245
TABLE 91 NORTH AMERICAN SURGICAL WOUNDS MARKET, BY TYPE,
(2013-2021) ($MN) 246
TABLE 92 NORTH AMERICAN WOUND CLOSURE and ADVANCED WOUND CARE MARKETREVENUE, BY END-USER, (2013-2021) ($MN) 247
TABLE 93 EUROPEAN WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCT, (2013-2021) ($MN) 250
TABLE 94 EUROPEAN PRIMARY WOUND CLOSURE MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 251
TABLE 95 EUROPEAN SURGICAL SUTURES MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 252
TABLE 96 EUROPEAN SUTURE MARKET, BY TYPE, (2013-2021) ($MN) 253
TABLE 97 EUROPEAN ADHESIVE and SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 254
TABLE 98 EUROPEAN SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 254
TABLE 99 EUROPEAN NATURAL SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 255
TABLE 100 EUROPEAN SYNTHETIC SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 256
TABLE 101 EUROPEAN HAEMOSTATS MARKET, BY TYPE, (2013-2021) ($MN) 257
TABLE 102 EUROPEAN SECONDARY WOUND CLOSURE MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 258
TABLE 103 EUROPEAN THERAPY BASED DEVICES MARKET, BY TYPE,
(2013-2021) ($MN) 259
TABLE 104 EUROPEAN BIOLOGICS MARKET, BY TYPE, (2013-2021) ($MN) 260
TABLE 105 EUROPEAN WOUND CLOSURE AND ADVANCED WOUND CARE MARKETREVENUE, BY APPLICATION, (2013-2021) ($MN) 261
TABLE 106 EUROPEAN ULCERS MARKET, BY TYPE, (2013-2021) ($MN) 262
TABLE 107 EUROPEAN SURGICAL WOUNDS MARKET, BY TYPE, (2013-2021) ($MN) 263
TABLE 108 EUROPEAN WOUND CLOSURE and ADVANCED WOUND CARE MARKETREVENUE, BY END-USER, (2013-2021) ($MN) 264
TABLE 109 ASIA-PACIFIC WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCT, (2013-2021) ($MN) 268
TABLE 110 ASIA-PACIFIC PRIMARY WOUND CLOSURE MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 269
TABLE 111 ASIA-PACIFIC SURGICAL SUTURES MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 270
TABLE 112 ASIA-PACIFIC SUTURE MARKET, BY TYPE, (2013-2021) ($MN) 271
TABLE 113 ASIA-PACIFIC ADHESIVE and SEALANTS MARKET, BY TYPE,
(2013-2021) ($MN) 272
TABLE 114 ASIA-PACIFIC SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 272
TABLE 115 ASIA-PACIFIC NATURAL SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 273
TABLE 116 ASIA-PACIFIC SYNTHETIC SEALANTS MARKET, BY TYPE,
(2013-2021) ($MN) 274
TABLE 117 ASIA-PACIFIC HAEMOSTATS MARKET, BY TYPE, (2013-2021) ($MN) 275
TABLE 118 ASIA-PACIFIC SECONDARY WOUND CLOSURE MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 276
TABLE 119 ASIA-PACIFIC THERAPY BASED DEVICES MARKET, BY TYPE,
(2013-2021) ($MN) 277
TABLE 120 ASIA-PACIFIC BIOLOGICS MARKET, BY TYPE, (2013-2021) ($MN) 278
TABLE 121 ASIA-PACIFIC WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 279
TABLE 122 ASIA-PACIFIC ULCERS MARKET, BY TYPE, (2013-2021) ($MN) 280
TABLE 123 ASIA-PACIFIC SURGICAL WOUNDS MARKET, BY TYPE, (2013-2021) ($MN) 281
TABLE 124 ASIA-PACIFIC WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE, BY END-USER, (2013-2021) ($MN) 282
TABLE 125 ROW WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE,
BY PRODUCT, (2013-2021) ($MN) 285
TABLE 126 ROW PRIMARY WOUND CLOSURE MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 286
TABLE 127 ROW SURGICAL SUTURES MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 287
TABLE 128 ROW SUTURE MARKET, BY TYPE, (2013-2021) ($MN) 288
TABLE 129 ROW ADHESIVE and SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 289
TABLE 130 ROW SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 289
TABLE 131 ROW NATURAL SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 290
TABLE 132 ROW SYNTHETIC SEALANTS MARKET, BY TYPE, (2013-2021) ($MN) 291
TABLE 133 ROW HAEMOSTATS MARKET, BY TYPE, (2013-2021) ($MN) 292
TABLE 134 ROW SECONDARY WOUND CLOSURE MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 293
TABLE 135 ROW THERAPY BASED DEVICES MARKET, BY TYPE, (2013-2021) ($MN) 294
TABLE 136 ROW BIOLOGICS MARKET, BY TYPE, (2013-2021) ($MN) 295
TABLE 137 ROW WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE,
BY APPLICATION, (2013-2021) ($MN) 296
TABLE 138 ROW ULCERS MARKET, BY TYPE, (2013-2021) ($MN) 297
TABLE 139 ROW SURGICAL WOUNDS MARKET, BY TYPE, (2013-2021) ($MN) 298
TABLE 140 ROW WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE,
BY END-USER, (2013-2021) ($MN) 299
TABLE 141 MERGERS AND ACQUITIONS (2010-2015) 302
TABLE 142 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS and JOINT VENTURES (2010-2014) 309
TABLE 143 NEW PRODUCT LAUNCH (2010-2015) 313
TABLE 144 APPROVALS (2010-2015) 317
TABLE 145 BUSINESS EXPANSION (2010-2015) 319
TABLE 146 OTHER DEVELOPMENTS (2010-2015) 321
TABLE 147 3M: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 323
TABLE 148 3M: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 324
TABLE 149 3M: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 325
TABLE 150 ABBOTT LABORATORIES: TOTAL REVENUE AND RandD EXPENSES,
(2012-2014) ($MN) 330
TABLE 151 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS,
(2012-2014) ($MN) 331
TABLE 152 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY,
(2012-2014) ($MN) 332
TABLE 153 ACELITY LTD: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 338
TABLE 154 ACELITY LTD : TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 339
TABLE 155 ACELITY LTD : TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 340
TABLE 156 BAXTER INTERNATIONAL, INC.: TOTAL SALES AND RandD EXPENSES,
(2012-2014) ($MN) 344
TABLE 157 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY SEGMENTS,
(2012-2014) ($MN) 345
TABLE 158 BAXTER INTERNATIONAL, INC.: BIOSCIENCE, BY SEGMENTS,
(2012-2014) ($MN) 346
TABLE 159 BAXTER INTERNATIONAL, INC.: MEDICAL PRODUCTS, BY SEGMENTS, (2012-2014) ($MN) 346
TABLE 160 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY GEOGRAPHY,
(2012-2014) ($MN) 347
TABLE 161 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND RandD EXPENSES,
(2012-2014) ($MN) 354
TABLE 162 B.BRAUN MELSUNGEN AG: TOTAL REVENUE BY SEGMENTS,
(2012-2014) ($MN) 355
TABLE 163 B.BRAUN MELSUNGEN AG: TOTAL REVENUE BY GEOGRAPHY,
(2012-2014) ($MN) 356
TABLE 164 CARDINAL HEALTH, INC.: TOTAL REVENUE AND OPERATING EXPENSES, (2012-2014) ($MN) 363
TABLE 165 CARDINAL HEALTH, INC.: TOTAL REVENUE, BY SEGMENTS,
(2012-2014) ($MN) 364
TABLE 166 CARDINAL HEALTH, INC.: TOTAL REVENUE, BY GEOGRAPHY,
(2012-2014) ($MN) 365
TABLE 167 C.R.BARD INC: TOTAL REVENUE AND RandD EXPENSES, (2012-14) ($MN) 372
TABLE 168 C.R.BARD INC: TOTAL REVENUE, BY SEGMENTS, (2012-14) ($MN) 373
TABLE 169 COLOPLAST: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 378
TABLE 170 COLOPLAST: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN) 378
TABLE 171 COLOPLAST: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 379
TABLE 172 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 383
TABLE 173 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE BY SEGMENTS, (2012-2014) ($MN) 384
TABLE 174 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 385
TABLE 175 JOHNSON and JOHNSON: TOTAL REVENUE AND RandD EXPENSES,
(2012-2014) ($MN) 391
TABLE 176 JOHNSON and JOHNSON: TOTAL REVENUE, BY SEGMENTS,
(2012-2014) ($MN) 391
TABLE 177 JOHNSON and JOHNSON: TOTAL REVENUE, BY GEOGRAPHY,
(2012-2014) ($MN) 392
TABLE 178 MEDTRONIC INC.: TOTAL REVENUE AND RandD EXPENSES,
(2012-2014) ($MN) 398
TABLE 179 MEDTRONIC INC.: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN) 399
TABLE 180 MEDTRONIC INC.: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 400
TABLE 181 SMITH and NEPHEW PLC : TOTAL REVENUE AND RandD EXPENSES,
(2012-2014) ($MN) 407
TABLE 182 SMITH andNEPHEW PLC : TOTAL REVENUE, BY SEGMENTS,
(2012-2014) ($MN) 408
TABLE 183 SMITH and NEPHEW PLC : TOTAL REVENUE, BY GEOGRAPHY,
(2012-2014) ($MN) 409





































LIST OF FIGURES

FIGURE 1 GLOBAL WOUND CLOSURE and ADVANCED WOUND CARE MARKET SHARE,
BY GEOGRAPHY, (2013-2021) ($MN) 32
FIGURE 2 RESEARCH METHODOLOGY: WOUND CLOSURE and ADVANCED WOUND CARE MARKET 43
FIGURE 3 WOUND CLOSURE and ADVANCED WOUND CARE MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 44
FIGURE 4 WOUND CLOSURE and ADVANCED WOUND CARE MARKET: FORECASTING MODEL 45
FIGURE 5 WOUND CLOSURE and ADVANCED WOUND CARE MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION 46
FIGURE 6 WOUND CLOSURE and ADVANCED WOUND CARE MARKET: MARKET SEGMENTATION 52
FIGURE 7 MARKET DYNAMICS 55
FIGURE 8 WOUND CLOSURE and ADVANCED WOUND CARE MARKET:PATENT FILING BY MAJOR PLAYERS (2011-2015) 92
FIGURE 9 WOUND CLOSURE and ADVANCED WOUND CARE MARKET: PORTER'S ANALYSIS 95
FIGURE 10 WOUND CLOSURE and ADVANCED WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS 97
FIGURE 11 GLOBAL WOUND CLOSURE and ADVANCED WOUND CARE MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014 98
FIGURE 12 GLOBAL WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, (2013-2021) ($MN) 103
FIGURE 13 GLOBAL PRIMARY WOUND CLOSURE MARKET REVENUE, BY TYPE,
(2014 V'S 2021) ($MN) 106
FIGURE 14 GLOBAL SEALANTS MARKET SIZE, BY TYPE, 2014 V'S 2021 (%) 132
FIGURE 15 GLOBAL HAEMOSTATS MARKET SIZE, BY TYPE, (%) (2014) 148
FIGURE 16 GLOBAL SECONDARY WOUND CLOSURE MARKET REVENUE, BY TYPE,
(2014 V'S 2021) ($MN) 158
FIGURE 17 GLOBAL SECONDARY WOUND CLOSURE MARKET REVENUE, BY TYPE,
(2014 V'S 2021) ($MN) 167
FIGURE 18 GLOBAL WOUND CLOSURE and ADVANCED WOUND CARE MARKET REVENUE, BY APPLICATIONS, (2014 V'S 2021) ($MN) 185
FIGURE 19 GLOBAL SURGICAL WOUNDS APPLICATION MARKET SIZE,
BY THERAPEUTIC AREA, (2014 V'S 2021) ($MN) 199
FIGURE 20 WOUND CLOSURE and ADVANCED WOUND CAREGLOBAL MARKET REVENUE, BY END-USER, (2013 V'S 2021) ($MN) 222
FIGURE 21 GLOBAL WOUND CLOSURE and ADVANCED WOUND CARE MARKETREVENUE, BY REGION (2013-2021) ($MN) 230
FIGURE 22 NORTH AMERICAN WOUND CLOSURE and ADVANCED WOUND CARE MARKETSIZE, BY PRIMARY WOUND CLOSURE, SECONDARY WOUND CLOSURE, APPLICATION and END-USER OUTLOOK, (2014 V'S 2021) 232
FIGURE 23 EUROPEAN WOUND CLOSURE and ADVANCED WOUND CARE MARKETSIZE,
BY PRIMARY WOUND CLOSURE , SECONDARY WOUND CLOSURE, APPLICATION and END-USER OUTLOOK, (2014 V'S 2021) 249
FIGURE 24 ASIA-PACIFIC WOUND CLOSURE and ADVANCED WOUND CARE MARKETSIZE, BY PRIMARY WOUND CLOSURE, SECONDARY WOUND CLOSURE, APPLICATION and END-USER OUTLOOK, (2014 V'S 2021) 267
FIGURE 25 ROW WOUND CLOSURE and ADVANCED WOUND CARE MARKETSIZE, BY PRIMARY WOUND CLOSURE, SECONDARY WOUND CLOSURE, APPLICATION and END-USER OUTLOOK, (2014 V'S 2021) 284
FIGURE 26 KEY GROWTH STRATEGIES (2015-2010) 300
FIGURE 27 SWOT: 3M 328
FIGURE 28 SWOT: ABBOTT LABORATORIES 336
FIGURE 29 SWOT: ACELITY LTD 343
FIGURE 30 SWOT: BAXTER INTERNATIONAL, INC. 352
FIGURE 31 SWOT ANALYSIS: B.BRAUN MELSUNGEN AG 361
FIGURE 32 SWOT: CARDINAL HEALTH, INC. 370
FIGURE 33 SWOT ANALYSIS: C.R.BARD INC. 376
FIGURE 34 SWOT: COLOPLAST 382
FIGURE 35 SWOT: INTEGRA LIFESCIECES CORPORATION 389
FIGURE 36 SWOT: JOHNSON and JOHNSON 396
FIGURE 37 SWOT: MEDTRONIC INC 405
FIGURE 38 SWOT: SMITH and NEPHEW PLC 412



Companies Mentioned
3M
ABBOTT LABORATORIES
ACELITY LTD
BAXTER INTERNATIONAL, INC
B.BRAUN MELSUNGEN AG
CARDINAL HEALTH, INC.
C.R.BARD INC.
COLOPLAST
INTEGRA LIFESCIECES CORPORATION
JOHNSON and JOHNSON
MEDTRONIC INC
SMITH and NEPHEW PLC
LIST OF COMPANIES MENTIONED IN THE REPORT
3-D Matrix Europe SAS
3M
Abbott Laboratories
Acelity Ltd
Ackermann Instruments
AD Surgical
Adhesive Research, Inc.
Adhezion Biomedical
Advanced BioHealing
Advanced Medical Solutions Group plc
Aedicell, Inc.
Aerobella Medical, LLC
Alon MedTech Ventures
Altaylar Medical
Angelini Pharma, Inc.
Anodyhe Therapy LLC
Apollo Endosurgery
Applied Medical Resources Corporation
ArjoHunHeigh
Assut Medical Sarl
Atmos Medizin Technik
Atromat
B.Braun Melsungen
Baxter International
Beiersdorf
BioElectronics
Bristol-Myers Squibb
BSN Medical
C.R.Bard
Cardinal Health, Inc
Chemence
Clinisut
Cohera Medicals
Cohesion technologies
Coloplast
Conmed
ConvoTech
Cordis Corporation
CP Medical
CryoLife Inc
Daewoong Pharmaceutical
Davol Inc.
De Royal
DemeTech
Dentsply Limited
Derma Sciences
Diapulse Corporation of America
Dogsan
Dolphin Sutures
Dukal Corporation
Dynasil Corporation of America
Dynek
Endo Evolution
ETC Biomedical System
Fine surgical
Flink Engineering Pty Ltd
Futura Surgicare Pvt Ltd
Gambro AB
Gelita Medical
GEM italy
Getinge Group (Maquet)
GluStitch Inc
Grena Ltd
Gulf Coast Hyperbaric, Inc.
Haemacure Corporation
Halyard health
HealthPoint Biotherapeutics Ltd
Henkel Loctite Corporation
HLA lifecare Ltd
Hollister
Holycon
Huaian Top Medical Instruments Co., Ltd.
Hyperbranch Medical Technology
IHC Hytech B.V.
Incisive Surgical, Inc.
Integra Lifesciences
Internacional Farmaceutica
Interpore Cross International, Inc.
Invacare Corporation
Johnson and Johnson
Katecho Inc
Keraplast
Kerecis
Kono Seisakusho
Laser Needle
LifeBond
LifeNet Health, Inc.
Lohmann and Rauscher
LSI Solutions
Mani.co
Medela
MediChoice

Medline industries
Medtronic Inc
MEYER-HAAKE
Molynlycke healthcare
Nuo therapeutics
Ocular Therapeutics
Organogenesis
Orthovita Inc
OxyHeal Health Group
Paul Hartmann
Peters Surgical
Prospera Technologies LLC
Protein Polymer Technologies, Inc. )
Purple surgicals
Qingdao Kingston Medical Devices Co.
Riverpoint Medical
Samyang Biopharmaceuticals
Sealantis
Sechrist Industries, Inc.
Shanghai Tianqing
Shanxian Huayu Suture Materials Co., Ltd.
SMB Corporation Of India
SMI sutures
Smith and Nephew
Soring GmbH
SOS Medical Group
Southington Tool and Manufacturing Corp
Spiracur, Inc.
St. Jude Medical
Stratatech Corporation
Stryker Corporation
Surgical Specialties Corporation
Surgiform Technology ltd
Suture
Sweden and Martina SPA
Systagenix
Taiwan Surgicals
Tanaxiz Medical
TECHNO-GAZ
TEI Biosciences Inc
Teknimed Corporation
Teleflex Medical
The medicine company
Thermo Genesis Corp
Thor Laser
Tissueseal
Unik Surgical Sutures MFG
United Medical
Urgo Medical
Vesocclude medical LLC
Vigilenz
Vingmed
ViroMed Co., Ltd
Vivostat A/S
Vomaris Wound Care
W.L. Gore and Associates
Welfare Medicles
Wound care technologies
Wuttan VSO Medical Science and Technology Co
Wuxi BIOT Biology Technology Co., Ltd
Yafho wound care
Zhejiang Aoki Medical Dressing co. ltd
Zimmer holdings
Zymogenetics Inc

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Advanced Wound Care Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Advanced Wound Care Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Advanced Wound Care Management Market: Overview The market for wound care is growing phenomenally, due to growing advancement is treating complex wounds. Advanced wound care market is anticipated to grow ...

Animal Wound Care Market by Product Animal & End User - Global Forecast to 2021

Animal Wound Care Market by Product Animal & End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global animal wound care market is estimated to grow at a CAGR of 6.7% from 2016 to 2021, to reach USD 1,134.0 million by 2021 from USD 818.8 million in 2016. The growth of this market is mainly attributed ...

Burn Care Market by Product, Biologics, Traditional), Depth, End-Users, Physician Clinics, Homecare - Forecast to 2021

Burn Care Market by Product, Biologics, Traditional), Depth, End-Users, Physician Clinics, Homecare - Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The burn care market is expected to reach USD 2.33 billion by 2021 from USD 1.68 billion in 2016, at a CAGR of 6.8% from 2016 to 2021. Market growth can be attributed to factors such as rising incidence ...

Global Advanced Wound Care Industry

September 2016 $ 4950

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.